Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Possible link between COVID-19 and hair loss; more research needed.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

PRP therapy significantly improves hair thickness and density in male pattern baldness.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Using steroids can increase the risk of heart problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

A new wearable device stops hair loss and boosts hair growth safely.

Severe and early hair loss may indicate a higher risk of heart disease.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

PRP with finasteride is better for hair regrowth than minoxidil with finasteride.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Regular aerobic exercise for over 60 minutes can delay and improve androgenic alopecia symptoms.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.